High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$26.7M
$26,657,462
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Other
|
2026-01-09 | $391,840x2 | M | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2026-01-09
$12,963,305MEGAx29
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2026-01-09 | $12,963,305MEGAx29 | S | Form 4 |
|
MDGL
M
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
Equity Compensation
2025-12-10
$391,840x2
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
Equity Compensation
|
2025-12-10 | $391,840x2 | M | Form 4 |
|
MDGL
S
MADRIGAL PHARMACEUTICALS, INC.
FRIEDMAN PAUL A
• Director
10b5-1 Sell
2025-12-10
$13,694,158MEGAx9
|
||||||
| MDGL |
MADRIGAL PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-10 | $13,694,158MEGAx9 | S | Form 4 |